2023年5月5日

分享这篇文章提供的新闻分享这篇文章普利茅斯会议上,Pa。,2023年5月5日/PRNewswire/ -- INOVIO (NASDAQ: INO ), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that Jacqueline Shea, Ph.D., President and CEO, will present at the 2023 RBC Capital Markets Global Healthcare Conference. 2023 RBC Capital Markets Global Healthcare Conference Date: Wednesday, May 17, 2023 Time: 4:05 PM ET Format: Fireside Chat During the conference, Dr. Shea and members of INOVIO's management team will conduct one-on-one meetings with registered investors. A webcast of the presentation will be available on the INOVIO Investor Relations Events page at https://ir.inovio.com/events-and-presentations/default.aspx . A replay of the webcast will be available for 90 days after the date of the presentation. About INOVIO INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's DNA medicines in development are delivered using its investigational proprietary smart device, CELLECTRA®, to produce immune responses against targeted pathogens and cancers. For more information, visit www.inovio.com . Contacts Investors: Thomas Hong (267) 440-4298 [email protected] SOURCE INOVIO Pharmaceuticals, Inc.